Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach.

Romero-López JP. et al, (2021), Journal of medical virology, 93, 2029 - 2038

Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection.

Gibbins MP. et al, (2020), Infection and immunity, 88

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination

Müller K. et al, (2020)

Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells-Comparison of Their Performances in ELISA.

Bagno FF. et al, (2020), Viruses, 12

Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon.

Soares IF. et al, (2020), Scientific reports, 10

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates.

Kim YC. et al, (2020), Vaccines, 8

Balanced immunity is key for a successful dengue vaccine.

Reyes-Sandoval A., (2020), The Lancet. Infectious diseases, 20, 761 - 762

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines.

López-Camacho C. et al, (2020), Vaccines, 8

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein.

Atcheson E. and Reyes-Sandoval A., (2020), Vaccine, 38, 4346 - 4354

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection.

Mann GS. et al, (2020), PLoS neglected tropical diseases, 14

COVID-19 vaccines: breaking record times to first-in-human trials.

Kim YC. et al, (2020), NPJ vaccines, 5

Optimization of Small-Scale Production of Zika Virus Envelope Glycoprotein by Transient Expression in HEK293 Cells for ELISA.

Kim YC. et al, (2020), Methods in molecular biology (Clifton, N.J.), 2142, 103 - 112

Production and Purification of Zika Virus NS1 Glycoprotein in HEK293 Cells.

Kim YC. et al, (2020), Methods in molecular biology (Clifton, N.J.), 2142, 93 - 102

Sero-prevalence of arthropod-borne viral infections among Lukanga swamp residents in Zambia.

Chisenga CC. et al, (2020), PloS one, 15

A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins.

Hancock G. et al, (2019), Scientific reports, 9

Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention.

Blight J. et al, (2019), Vaccines, 7

A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease

Kroon Campos R. et al, (2019), Pathogens, 8, 231 - 231

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers

López-Camacho None. et al, (2019), Pathogens, 8, 216 - 216

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.

Slon-Campos JL. et al, (2019), Nature immunology, 20, 1291 - 1298

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.

Milicic A. et al, (2019), Scientific reports, 9

Load More

1
2
3
4
5

Include forthcoming?